New contrast agent combination could usher in a new era of vascular systems biology

New contrast agent combination could usher in a new era of vascular systems biology
Multiple views of a human breast cancer tumor and surrounding tissue that were made using the novel contrast agent combination, including MRI, fluorescence and CT scan. Credit: American Physiological Society

A new contrast agent combination for imaging tumor samples enhances imaging and data extraction and thus benefits image-based modeling of tumor processes. The discovery will be presented today at the American Physiological Society (APS) Interface of Mathematical Models and Experimental Biology: Role of the Microvasculature Conference in Scottsdale, Ariz.

Image-based systems biology combines images of the subject of study with computer and mathematical modeling to gain a fuller understanding of the underlying biological processes at multiple levels. For example, in vascular systems biology, researchers could extract data about the diameters, shapes and paths of connecting to calculate factors such as the movement of fluid and cells through those vessels. When looking at the vasculature around and inside a tumor, such simulations could reveal about how the tumor extracts nutrients from the body, how it metastasizes or how to better deliver drugs and target therapies.

One difficulty with imaging tumors has been that employing a contrast agent necessary for one imaging method could preclude the use of another. Akanksha Bhargava, Ph.D., works in the lab of Arvind Pathak, Ph.D., at Johns Hopkins University (www.pathaklab.org) in Baltimore. Pathak has made strides in combining data from multiple and spatial scales to develop a more complete representation of the tumor environment. Bhargava explains that "this new combination of a radio-opaque CT agent, … magnetic resonance-visible and fluorescent agents does not interfere with other image contrast mechanisms."

The team has already used the new combination of agents to assemble MRI, CT and optical imaging data of different 3-D tissues, allowing for visualization from the cellular- to whole-tissue level with complementary contrast mechanisms. They hope to use it to develop an "atlas for cancer systems biology" that curates digitized results of the images this approach will make possible. When completed, the contents of the digitized atlas would be free and downloadable for researchers around the globe.

"We believe this new approach will encourage novel applications and usher in a new era of image-based systems biology research," Pathak says.


Explore further

'Google Maps' for cancer: Image-based computer model reveals finer details of tumor blood flow

More information: The APS Interface of Mathematical Models and Experimental Biology: Role of the Microvasculature will be held September 11–14 in Scottsdale, Ariz.
Citation: New contrast agent combination could usher in a new era of vascular systems biology (2019, September 16) retrieved 23 October 2019 from https://phys.org/news/2019-09-contrast-agent-combination-usher-era.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
7 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more